Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.3 USD | +1.98% | -1.93% | -24.71% |
Apr. 23 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
Apr. 22 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
Financials (USD)
Sales 2024 * | 585M | Sales 2025 * | 1.08B | Capitalization | 8.24B |
---|---|---|---|---|---|
Net income 2024 * | -316M | Net income 2025 * | -92M | EV / Sales 2024 * | 12.5 x |
Net cash position 2024 * | 928M | Net cash position 2025 * | 835M | EV / Sales 2025 * | 6.88 x |
P/E ratio 2024 * |
-41.9
x | P/E ratio 2025 * |
-141
x | Employees | 1,800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99% |
Latest transcript on Legend Biotech Corporation
1 day | +1.98% | ||
1 week | -1.93% | ||
Current month | -19.24% | ||
1 month | -18.96% | ||
3 months | -19.89% | ||
6 months | -29.52% | ||
Current year | -24.71% |
Managers | Title | Age | Since |
---|---|---|---|
Ying Huang
CEO | Chief Executive Officer | 51 | 19-06-30 |
Lori Macomber
DFI | Director of Finance/CFO | 53 | 19-08-31 |
Tracy Luo
CTO | Chief Tech/Sci/R&D Officer | - | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ying Huang
CEO | Chief Executive Officer | 51 | 19-06-30 |
Corazon Sanders
BRD | Director/Board Member | 67 | 20-04-30 |
Li Zhu
BRD | Director/Board Member | 74 | 20-11-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.08% | 4 M€ | -27.92% | ||
1.18% | 2 M€ | -14.14% | ||
0.99% | 2 M€ | -16.59% | - | |
0.95% | 11 M€ | -6.03% | - | |
0.58% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 45.3 | +1.98% | 895,893 |
24-04-25 | 44.42 | -1.66% | 1,849,777 |
24-04-24 | 45.17 | -4.81% | 1,089,079 |
24-04-23 | 47.45 | +0.83% | 1,813,170 |
24-04-22 | 47.06 | +1.88% | 756,637 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.71% | 8.24B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- LEGN Stock